Search Results1-13 of  13

  • HAMAGUCHI Tomoya ID: 9000018825445

    Division of Innovative Diabetes Treatment, Department of Internal Medicine, Hyogo College of Medicine (2011 from CiNii)

    Articles in CiNii:1

    • Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus (2011)
  • HAMAGUCHI Tomoya ID: 9000020944927

    Second Department of Internal Medicine, Osaka University Medical School (1992 from CiNii)

    Articles in CiNii:1

    • Treatment of Myogenic Hyperuricemia:Allopurinol Effects in Muscle Phosphofructokinase Deficiency (1992)
  • HAMAGUCHI Tomoya ID: 9000020951865

    The Second Department of Internal Medicine, Osaka University Medical School (1992 from CiNii)

    Articles in CiNii:1

    • Molecular Basis of Myogenic Hyperuricemia:Analysis of Tissue-specific Expression of Phosphofructokinase-M Gene Transcripts (1992)
  • HAMAGUCHI Tomoya ID: 9000021942350

    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine (2009 from CiNii)

    Articles in CiNii:1

    • Role of Macrophages in the Development of Pancreatic Islet Injury in Spontaneously Diabetic Torii Rats (2009)
  • HAMAGUCHI Tomoya ID: 9000259322380

    Division of Innovative Diabetes Treatment, Hyogo College of Medicine (2013 from CiNii)

    Articles in CiNii:1

    • Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin (2013)
  • Hamaguchi Tomoya ID: 9000020938653

    The Second Department of Internal Medicine, Osaka University Medical School (1997 from CiNii)

    Articles in CiNii:1

    • Proper management of hyperuricemia and gout::investigation into general practitioners and comparison with the consensus statement by the Japan Purine and Pyrimidine Association Meeting 1996. (1997)
  • Hamaguchi Tomoya ID: 9000256600934

    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine (2002 from CiNii)

    Articles in CiNii:1

    • Clinical Significance of PAI-1 for Lacunar Infarction in Type 2 Diabetic Patients. (2002)
  • Hamaguchi Tomoya ID: 9000257806567

    Division of Innovative Diabetes Treatment, Hyogo College of Medicine, Nishinomiya 663-8501, Japan (2014 from CiNii)

    Articles in CiNii:1

    • Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes (2014)
  • Hamaguchi Tomoya ID: 9000258082439

    Division of Diabetes & Metabolism, Department of Internal Medicine, Hyogo College of Medicine (2005 from CiNii)

    Articles in CiNii:1

    • Factors Affecting the Improvement in Glycemic Control after Switching Patients on Multiple Daily Insulin Injections from Regular Insulin to a Quick-acting Insulin Analogue. (2005)
  • Hamaguchi Tomoya ID: 9000258084141

    Division of Diabetes and Metabolism, Department of Internal Medicine, Hyogo College of Medicine (2009 from CiNii)

    Articles in CiNii:1

    • Aripiprazole Aggravates Type 2 Diabetes Mellitus Blood Glucose Control in a Patient with Schizophrenia (2009)
  • Hamaguchi Tomoya ID: 9000258418425

    Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University. (2000 from CiNii)

    Articles in CiNii:1

    • Management of hyperuricemia and gout by the Japanese general practitioners: difference between the results of two questionnaire surveys in 1996 and 1999. (2000)
  • Hamaguchi Tomoya ID: 9000283501745

    Division of Innovative Diabetes Treatment, Hyogo College of Medicine (2013 from CiNii)

    Articles in CiNii:1

    • Effects of Exenatide on the Glycemic Control and Eating Behavior in Obese Japanese Patients with Type 2 Diabetes Mellitus (2013)
  • Hamaguchi Tomoya ID: 9000283502136

    Division of Innovative Diabetes Treatment, Department of Internal Medicine, Hyogo College of Medicine (2014 from CiNii)

    Articles in CiNii:1

    • Consensus Statement on Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring (2014)
Page Top